Elanders AB: Quarterly Report January - September 2026

January - September 2026Net sales amounted to MSEK 8,737 (9,148), which corresponded to an organic growth of three percent compared to the same period last year, excluding acquisitions and discontinue ...

Argentina Metals Corp.: Argentina Metals Announces Insider-Led Private Placement for up to $3 Million CAD

Argentina Metals Corp. (TSXV: VLLC) (OTCQB: VLLCF) (FSE: VA5) ("VLLC" or the "Company") is pleased to announce a non-brokered private ...

Antimony Resources Corp.: Antimony Resources Corp. Announces Closing of Financing

Antimony Resources Corp. (CSE: ATMY) (OTCQB: ATMYF) (FSE: K8J0) (the "Company" or "ATMY") is pleased to announce that it has closed its ...

S&P Dow Jones Indices: MSG Rangers and Huron Consulting Group Set to Join S&P SmallCap 600

S&P Dow Jones Indices will make the following changes to the S&P SmallCap 600: MSG Rangers Inc. (NYSE: MSGR) will be added ...

Lunai Bioworks Inc.: Lunai Bioworks Announces Receipt of Nasdaq Determination and Intention to Voluntarily Delist and Deregister

Lunai Bioworks Inc. (Nasdaq: LNAI) (the "Company") announced that on October 21, 2026, it received a letter from ...

Oakworth Capital Inc. Reports 19% Growth in Net Income

Oakworth Capital Inc. (OTCQX: OAKC) reported 19% net income growth and 13% diluted EPS growth in the year-to-date period ...

ExpreS2ion Biotech Holding AB: ExpreS2ion Provides ES2B-C001 Phase I Update: All Patients Enrolled and Updated Readout Timing

Hørsholm, Denmark, 23 October 2026 - ExpreS2ion Biotech Holding AB's affiliate ExpreS2ion Biotechnologies ApS ("ExpreS2ion"), a clinical-stage biotechnology company with a pipeline of novel immunother ...

Addnode Group AB: Interim Report January 1-September 30, 2026

Significant earnings improvement"Organic growth, acquisitions and enhanced efficiency contributed to a significant earnings improvement for Addnode Group. During the quarter, we secured our largest co ...

Storskogen Group AB: Interim report Q3 2026

"The third quarter results marked another step in the right direction. Sales increased by 4 percent and adjusted EBITA by 6 percent, with improved profitability and positive organic growth in both sal ...

Acconeer AB: Interim report Q3 2026 - record volume shipped and continued revenue growth

In the third quarter of 2026 Acconeer delivered half a million sensors which is a new record. The revenue amounted to 23.5 MSEK, a growth with 42% compared to the same period last year, making it the ...

Biovica International AB: Biovica announces outcome of the rights issue

Biovica International AB (publ) ("Biovica" or the "Company") hereby announces the outcome of the Company's rights issue of B-shares with preferential rights for existing shareholders, in which the sub ...
Finanznachrichten

Novartis Pharma AG: Kisqali shows clinically meaningful overall survival in broadest HR+/HER2- early breast cancer population at high risk of recurrence

Six-year NATALEE analysis showed ~20% reduction in risk of death compared to ET alone 1 Benefit increased over time in invasive disease-free survival and across key secondary endpoints 1-3 Patients ...